Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2009, Article ID 803409, 4 pages
Research Article

Lack of Antilipoprotein Lipase Antibodies in Takayasu's Arteritis

1Disciplina de Reumatologia, Faculdade de Medicina da Universidade de São Paulo, 0124-6903 São Paulo, SP, Brazil
2Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, 52621 Tel-Hashomer, Israel

Received 8 April 2009; Accepted 23 May 2009

Academic Editor: Eiji Matsuura

Copyright © 2009 Jozélio Freire de Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Reichlin, J. Fesmire, A. I. Quintero-Del-Rio, and M. Wolfson-Reichlin, “Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 46, no. 11, pp. 2957–2963, 2002. View at Publisher · View at Google Scholar
  2. J. F. de Carvalho, E. F. Borba, V. S. T. Viana, C. Bueno, E. P. Leon, and E. Bonfá, “Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3610–3615, 2004. View at Publisher · View at Google Scholar
  3. M. Kodera, I. Hayakawa, K. Komura et al., “Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglycride concentrations,” Journal of Rheumatology, vol. 32, no. 4, pp. 629–636, 2005. View at Google Scholar
  4. M. Noris, “Pathogenesis of Takayasu's arteritis,” Journal of Nephrology, vol. 14, no. 6, pp. 506–513, 2001. View at Google Scholar
  5. E. D. Korn, “Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart,” The Journal of Biological Chemistry, vol. 215, pp. 1–14, 1955. View at Google Scholar
  6. M. Yamato, J. W. Lecky, K. Hiramatsu, and E. Kohda, “Takayasu arteritis: radiographic and angiographic findings in 59 patients,” Radiology, vol. 161, no. 2, pp. 329–334, 1986. View at Google Scholar
  7. F. Numano, “Takayasu's arteritis: clinical aspects,” in Inflammatory Diseases of Blood Vessels, G. S. Hoffman and C. M. Weyand, Eds., pp. 455–466, Marcel Dekker, New York, NY, USA, 2002. View at Google Scholar
  8. W. P. Arend, B. A. Michel, D. A. Bloch et al., “The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis,” Arthritis and Rheumatism, vol. 33, no. 8, pp. 1129–1134, 1990. View at Google Scholar
  9. J. Siedel, E. O. Hägele, J. Ziegenhorn, and A. W. Wahlefeld, “Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency,” Clinical Chemistry, vol. 29, no. 6, pp. 1075–1080, 1983. View at Google Scholar
  10. P. Fossati and L. Prencipe, “Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide,” Clinical Chemistry, vol. 28, no. 10, pp. 2077–2080, 1982. View at Google Scholar
  11. G. R. Warnick, M. C. Cheung, and J. J. Albers, “Comparison of current methods for high-density lipoprotein cholesterol quantitation,” Clinical Chemistry, vol. 25, no. 4, pp. 596–604, 1979. View at Google Scholar
  12. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar
  14. V. Regitz-Zagrosek, E. Lehmkuhl, and S. Mahmoodzadeh, “Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease,” Gender Medicine, vol. 4, supplement 2, pp. S162–S177, 2007. View at Publisher · View at Google Scholar
  15. W. B. Kannel, M. C. Hjortland, P. M. McNamara et al., “Menopause and risk of cardiovascular disease. The Framingham study,” Annals of Internal Medicine, vol. 85, pp. 447–452, 1976. View at Google Scholar
  16. C. M. Williams, “Lipid metabolism in women,” Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 153–160, 2004. View at Publisher · View at Google Scholar
  17. W. V. Brown, “Lipoprotein disorders in diabetes mellitus,” Medical Clinics of North America, vol. 78, no. 1, pp. 143–161, 1994. View at Google Scholar
  18. G. R. Thompson, A. K. Soutar, F. A. Spengel et al., “Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyrodism in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 4, pp. 2591–2595, 1981. View at Google Scholar
  19. P.-O. Attman and P. Alaupovic, “Lipid and apolipoprotein profiles of uremic dyslipoproteinemia—relation to renal function and dialysis,” Nephron, vol. 57, no. 4, pp. 401–410, 1991. View at Google Scholar
  20. H. Zinger, Y. Sherer, and Y. Shoenfeld, “Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings,” Clinical Reviews in Allergy and Immunology, Nov 8, 2008 [Epub ahead of print]. View at Publisher · View at Google Scholar
  21. J. E. Salmon and M. J. Roman, “Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus,” The American Journal of Medicine, vol. 121, no. 10, supplement 1, pp. S3–S8, 2008. View at Publisher · View at Google Scholar
  22. E. F. Borba, C. T. L. Borges, and E. Bonfá, “Lipoprotein profile in limited systemic sclerosis,” Rheumatology International, vol. 25, no. 5, pp. 379–383, 2005. View at Publisher · View at Google Scholar
  23. A. H. Kao, J. M. Sabatine, and S. Manzi, “Update on vascular disease in systemic lupus erythematosus,” Current Opinion in Rheumatology, vol. 15, no. 5, pp. 519–527, 2003. View at Publisher · View at Google Scholar
  24. Y. Shoenfeld, “Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications,” Cleveland Clinic Journal of Medicine, vol. 69, supplement 2, pp. SII65–SII67, 2002. View at Google Scholar
  25. S. Praprotnik, B. Rozman, M. Blank, and Y. Shoenfeld, “Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis,” Wiener Klinische Wochenschrift, vol. 112, no. 15-16, pp. 660–664, 2000. View at Google Scholar
  26. M. Blank, I. Krause, T. Goldkorn, S. Praprotnik, and A. Livneh, “Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels,” Arthritis and Rheumatism, vol. 42, no. 7, pp. 1421–1432, 1999. View at Publisher · View at Google Scholar